BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8921370)

  • 21. JAK3 maps to human chromosome 19p12 within a cluster of proto-oncogenes and transcription factors.
    Hoffman SM; Lai KS; Tomfohrde J; Bowcock A; Gordon LA; Mohrenweiser HW
    Genomics; 1997 Jul; 43(1):109-11. PubMed ID: 9226382
    [No Abstract]   [Full Text] [Related]  

  • 22. Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog.
    Boggon TJ; Li Y; Manley PW; Eck MJ
    Blood; 2005 Aug; 106(3):996-1002. PubMed ID: 15831699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.
    Notarangelo LD; Mella P; Jones A; de Saint Basile G; Savoldi G; Cranston T; Vihinen M; Schumacher RF
    Hum Mutat; 2001 Oct; 18(4):255-63. PubMed ID: 11668610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and functional basis for JAK3-deficient severe combined immunodeficiency.
    Candotti F; Oakes SA; Johnston JA; Giliani S; Schumacher RF; Mella P; Fiorini M; Ugazio AG; Badolato R; Notarangelo LD; Bozzi F; Macchi P; Strina D; Vezzoni P; Blaese RM; O'Shea JJ; Villa A
    Blood; 1997 Nov; 90(10):3996-4003. PubMed ID: 9354668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.
    Pesu M; Candotti F; Husa M; Hofmann SR; Notarangelo LD; O'Shea JJ
    Immunol Rev; 2005 Feb; 203():127-42. PubMed ID: 15661026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells.
    Lai KS; Jin Y; Graham DK; Witthuhn BA; Ihle JN; Liu ET
    J Biol Chem; 1995 Oct; 270(42):25028-36. PubMed ID: 7559633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Janus kinases (Jaks).
    Yamaoka K; Saharinen P; Pesu M; Holt VE; Silvennoinen O; O'Shea JJ
    Genome Biol; 2004; 5(12):253. PubMed ID: 15575979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss-of-function JAK3 mutations in TMD and AMKL of Down syndrome.
    De Vita S; Mulligan C; McElwaine S; Dagna-Bricarelli F; Spinelli M; Basso G; Nizetic D; Groet J
    Br J Haematol; 2007 May; 137(4):337-41. PubMed ID: 17456055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic organization and chromosomal localization of a member of the MAP kinase phosphatase gene family to human chromosome 11p15.5 and a pseudogene to 10q11.2.
    Nesbit MA; Hodges MD; Campbell L; de Meulemeester TM; Alders M; Rodrigues NR; Talbot K; Theodosiou AM; Mannens MA; Nakamura Y; Little PF; Davies KE
    Genomics; 1997 Jun; 42(2):284-94. PubMed ID: 9192849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia.
    Bergmann AK; Schneppenheim S; Seifert M; Betts MJ; Haake A; Lopez C; Maria Murga Penas E; Vater I; Jayne S; Dyer MJ; Schrappe M; Dührsen U; Ammerpohl O; Russell RB; Küppers R; Dürig J; Siebert R
    Genes Chromosomes Cancer; 2014 Apr; 53(4):309-16. PubMed ID: 24446122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic cloning of a human heat shock protein 40 (Hsp40) gene (HSPF1) and its chromosomal localization to 19p13.2.
    Hata M; Okumura K; Seto M; Ohtsuka K
    Genomics; 1996 Dec; 38(3):446-9. PubMed ID: 8975727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk.
    Mitchell PJ; Barker KT; Shipley J; Crompton MR
    Oncogene; 1997 Sep; 15(12):1497-502. PubMed ID: 9333026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
    Sudbeck EA; Liu XP; Narla RK; Mahajan S; Ghosh S; Mao C; Uckun FM
    Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells.
    Verbsky JW; Bach EA; Fang YF; Yang L; Randolph DA; Fields LE
    J Biol Chem; 1996 Jun; 271(24):13976-80. PubMed ID: 8662778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAK3 inhibition as a new concept for immune suppression.
    Borie DC; Si MS; Morris RE; Reitz BA; Changelian PS
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1297-303. PubMed ID: 14758768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of the porcine TYK2 gene on SSC 2q1.3-->q2.1.
    Leeb T; Martins-Wess F; Kuiper H; Lassnig C; Distl O; Müller M
    Cytogenet Genome Res; 2004; 107(1-2):103-7. PubMed ID: 15305063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cloning and determination of the structure of a new human gene, homologous to Saccharomyces cerevisiae rad proteins].
    Loseva EF; Kalnin VV
    Genetika; 1999 Jun; 35(6):744-50. PubMed ID: 10505263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Jak3 maps to chromosome 8.
    Kono DH; Owens DG; Wechsler AR
    Mamm Genome; 1996 Jun; 7(6):476-7. PubMed ID: 8662243
    [No Abstract]   [Full Text] [Related]  

  • 39. Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs.
    Foussias G; Taylor SM; Yousef GM; Tropak MB; Ordon MH; Diamandis EP
    Biochem Biophys Res Commun; 2001 Jun; 284(4):887-99. PubMed ID: 11409877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activating Janus kinase pseudokinase domain mutations in myeloproliferative and other blood cancers.
    Constantinescu SN; Leroy E; Gryshkova V; Pecquet C; Dusa A
    Biochem Soc Trans; 2013 Aug; 41(4):1048-54. PubMed ID: 23863177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.